Safety and Tolerability of Loteprednol Etabonate 0.5% and Tobramycin 0.3% Ophthalmic Suspension in Pediatric Subjects

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.14, Iss.2, 2012-04, pp. : 119-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Loteprednol Etabonate: Alrex, Lotemax, Loteprednol, Loterox

Drugs in R&D, Vol. 3, Iss. 3, 2002-01 ,pp. : 154-157

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Conjunctivitis: Data from Six Clinical and Phase I Safety Studies

By Comstock Timothy L.

Clinical Drug Investigation, Vol. 30, Iss. 10, 2010-10 ,pp. : 675-685

Adis International

Access to resources Recommend Favorite

Loteprednol etabonate: Ocular hypertension: case report

Reactions Weekly, Vol. 1, Iss. 1392, 2012-01 ,pp. : 34-35

Adis International

Access to resources Recommend Favorite

Loteprednol etabonate protects against pollen in SAR

Inpharma, Vol. 1, Iss. 1482, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Bismuthyl Ecabet Suspension, a Novel Anti-Ulcer Agent, following Single and Multiple Oral Dose Administration in Healthy Chinese Subjects

By Wang Yongqing

Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. : 247-252

Adis International

Access to resources Recommend Favorite